Novel Anti-Obesity Properties of Palmaria mollis in Zebrafish and Mouse Models

被引:32
|
作者
Nakayama, Hiroko [1 ]
Shimada, Yasuhito [2 ,3 ,4 ]
Zang, Liqing [1 ]
Terasawa, Masahiro [5 ]
Nishiura, Kaoru [5 ]
Matsuda, Koichi [5 ]
Toombs, Charles [6 ]
Langdon, Chris [7 ,8 ]
Nishimura, Norihiro [1 ,2 ]
机构
[1] Mie Univ, Grad Sch Reg Innovat Studies, Tsu, Mie 5148507, Japan
[2] Mie Univ, Zebrafish Drug Screening Ctr, Tsu, Mie 5148507, Japan
[3] Mie Univ, Grad Sch Med, Dept Integrat Pharmacol, Tsu, Mie 5148507, Japan
[4] Mie Univ, Adv Sci Res Promot Ctr, Dept Bioinformat, Tsu, Mie 5148507, Japan
[5] Konan Chem Mfg Co Ltd, Yokaichi, Mie 5100103, Japan
[6] Oregon State Univ, Coll Business, Corvallis, OR 97331 USA
[7] Oregon State Univ, Coll Agr Sci, Hatfield Marine Sci Ctr, Coastal Oregon Marine Expt Stn, Corvallis, OR 97331 USA
[8] Oregon State Univ, Coll Agr Sci, Hatfield Marine Sci Ctr, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA
来源
NUTRIENTS | 2018年 / 10卷 / 10期
基金
日本科学技术振兴机构;
关键词
metabolic syndrome; animal model; comparative genomics; adipogenesis; DIET-INDUCED OBESITY; HIGH-FAT DIET; HEPATIC STEATOSIS; ADIPOCYTE DIFFERENTIATION; NUTRITIONAL-VALUE; ADIPOSE-TISSUE; EDIBLE SEAWEED; IN-VITRO; MICE; ANTIOXIDANT;
D O I
10.3390/nu10101401
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
(1) Background: The red seaweed Palmaria mollis (PM), which has a bacon-like taste, is increasingly being included in Western diets. In this study, we evaluate anti-obesity effects of PM using diet-induced obese (DIO) zebrafish and mice models. (2) Methods: We fed PM-containing feed to DIO-zebrafish and mice, and evaluated the anti-obesity effects We also analyzed gene expression changes in their liver and visceral adipose tissues (VAT). (3) Results: PM ameliorated several anti-obesity traits in both animals, including dyslipidaemia, hepatic steatosis, and visceral adiposity. In liver tissues of DIO-zebrafish and mice, PM upregulated gene expressions involved in peroxisome proliferator-activated receptor alpha (PPARA) pathways, and downregulated peroxisome proliferator-activated receptor gamma (PPARG) pathways, suggesting that the lipid-lowering effect of PM might be caused by activation of beta-oxidation and inhibition of lipogenesis. In VAT, PM downregulated genes involved in early and late adipocyte differentiation in zebrafish, but not in mice. (4) Conclusions: We have demonstrated that PM can prevent hepatic steatosis and visceral adiposity for the first time. Dietary supplementation of PM as a functional food may be suitable for obesity prevention and reduction in the prevalence of obesity-related diseases.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Novel anti-obesity drugs
    Proietto, J
    Fam, BC
    Ainslie, DA
    Thorburn, AW
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (06) : 1317 - 1326
  • [2] Novel anti-obesity drugs
    Tripp, B
    Ludvik, B
    ACTA MEDICA AUSTRIACA, 2004, 31 (04) : 133 - 138
  • [3] The utility of animal models to evaluate novel anti-obesity agents
    Vickers, Steven P.
    Jackson, Helen C.
    Cheetham, Sharon C.
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 164 (04) : 1248 - 1262
  • [4] A novel anti-obesity peptide that targets the hypothalamus
    Carty, Senegal
    NATURE REVIEWS ENDOCRINOLOGY, 2025, : 267 - 267
  • [5] The efficacy and safety of novel anti-obesity therapies
    Papazafiropoulou, A. K.
    Papanas, N.
    Melidonis, A.
    ARCHIVES OF HELLENIC MEDICINE, 2015, 32 (03): : 295 - 301
  • [6] Novel anti-obesity drugs and plasma lipids
    Nikolic, Dragana
    Toth, Peter P.
    Ferlita, Alessandra
    Di Bartolo, Vittoria
    Montalto, Giuseppe
    Banach, Maciej
    Rizzo, Manfredi
    CLINICAL LIPIDOLOGY, 2014, 9 (02) : 179 - 187
  • [7] Novel anti-obesity drugs for people with HIV
    Chandiwana, Nomathemba
    Manne-Goehler, Jennifer
    Calmy, Alexandra
    Gaayeb, Lobna
    Venter, Willem
    LANCET HIV, 2024, 11 (08): : e502 - e503
  • [8] Substance P as a novel anti-obesity target
    Karagiannides, Jordanes
    Espinoza, Daniel
    Torres, Daniel
    Tseng, Yu-hua
    Pothoulakis, Charalabos
    Kokkotou, Efi
    GASTROENTEROLOGY, 2007, 132 (04) : A542 - A542
  • [9] Substance P as a novel anti-obesity target
    Karagiannides, Iordanes
    Torres, Daniel
    Tseng, Yu-Hua
    Bowe, Collin
    Carvalho, Eugenia
    Espinoza, Daniel
    Pothoulakis, Charalabos
    Kokkotou, Efi
    GASTROENTEROLOGY, 2008, 134 (03) : 747 - 755
  • [10] Serotonergic targets for novel anti-obesity drugs
    Simansky, K. J.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 127 - 127